Sasha Damouni Ellis is responsible for all corporate communications, advocacy, and investor relations at Marinus.
Ms. Damouni brings close to 20 years of healthcare experience, including financial communications, issues management, and executive visibility, to Marinus.
Immediately prior to joining the company, Ms. Damouni was Director of External Communications and Media Relations for Bayer U.S., where she drove external brand-building strategies in therapeutic areas of oncology, hemophilia, cardio-pulmonary, and women’s health. Prior to Bayer, she was a Senior Healthcare Journalist at Bloomberg News where she focused on articles related to high profile FDA advisory committee meetings, drugs in development, intellectual property, and mergers and acquisitions. Ms. Damouni launched and was Global Editor of BioPharm Insight, formerly a division of the Financial Times Group, where she managed a group of three analysts and nine journalists in London and New York.
Ms. Damouni has also held roles at Mergermarket, and a number of leading international newspapers. She earned her Master of Arts from City, University of London’s Graduate School of Journalism, in the United Kingdom, and her Bachelor of Arts Degree from Richmond, the American International University in London, United Kingdom.